Achmea Investment Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-480,352
| Closed | -$53.3M | – | 195 |
|
|
2025
Q3 | $53.3M | Buy |
480,352
+24,564
| +5% | +$2.79M | 0.66% | 28 |
|
|
2025
Q2 | $50.5M | Buy |
455,788
+54,576
| +14% | +$5.81M | 0.65% | 30 |
|
|
2025
Q1 | $45M | Buy |
401,212
+150,624
| +60% | +$15.5M | 0.65% | 32 |
|
|
2024
Q4 | $23.1M | Buy |
250,588
+5,244
| +2% | +$472K | 0.38% | 61 |
|
|
2024
Q3 | $20.6M | Sell |
245,344
-140,267
| -36% | -$10.7M | 0.34% | 75 |
|
|
2024
Q2 | $26.5M | Buy |
385,611
+71,380
| +23% | +$4.76M | 0.47% | 43 |
|
|
2024
Q1 | $23M | Sell |
314,231
-19,364
| -6% | -$1.49M | 0.44% | 50 |
|
|
2023
Q4 | $27M | Sell |
333,595
-74,953
| -18% | -$5.83M | 0.56% | 35 |
|
|
2023
Q3 | $30.6M | Buy |
408,548
+49,096
| +14% | +$3.78M | 0.67% | 29 |
|
|
2023
Q2 | $27.7M | Buy |
359,452
+71,866
| +25% | +$5.73M | 0.58% | 31 |
|
|
2023
Q1 | $23.9M | Buy |
287,586
+103,842
| +57% | +$8.6M | 0.69% | 27 |
|
|
2022
Q4 | $14.8M | Buy |
183,744
+13,788
| +8% | +$1.09M | 0.5% | 43 |
|
|
2022
Q3 | $10.5M | Sell |
169,956
-8,378
| -5% | -$528K | 0.37% | 61 |
|
|
2022
Q2 | $11M | Buy |
178,334
+27,399
| +18% | +$1.7M | 0.36% | 62 |
|
|
2022
Q1 | $8.97M | Buy |
150,935
+2,997
| +2% | +$192K | 0.23% | 108 |
|
|
2021
Q4 | $10.7M | Buy |
147,938
+7,711
| +5% | +$531K | 0.51% | 44 |
|
|
2021
Q3 | $9.79M | Sell |
140,227
-22,620
| -14% | -$1.59M | 0.3% | 92 |
|
|
2021
Q2 | $11.2M | Sell |
162,847
-24,420
| -13% | -$1.63M | 0.38% | 53 |
|
|
2021
Q1 | $12.1M | Buy |
187,267
+15,099
| +9% | +$974K | 0.42% | 46 |
|
|
2020
Q4 | $10M | Sell |
172,168
-3,951
| -2% | -$238K | 0.36% | 61 |
|
|
2020
Q3 | $11.1M | Buy |
+176,119
| New | +$12.2M | 0.46% | 44 |
|
|
2020
Q1 | – | Sell |
-211,287
| Closed | -$13.7M | – | 369 |
|
|
2019
Q4 | $13.7M | Sell |
211,287
-26,322
| -11% | -$1.71M | 0.53% | 41 |
|
|
2019
Q3 | $15.1M | Buy |
237,609
+4,996
| +2% | +$327K | 0.59% | 36 |
|
|
2019
Q2 | $15.7M | Sell |
232,613
-7,682
| -3% | -$505K | 0.6% | 34 |
|
|
2019
Q1 | $15.6M | Buy |
240,295
+28,449
| +13% | +$1.89M | 0.65% | 34 |
|
|
2018
Q4 | $13.3M | Buy |
211,846
+18,916
| +10% | +$1.32M | 0.61% | 37 |
|
|
2018
Q3 | $14.9M | Sell |
192,930
-56,327
| -23% | -$4.25M | 0.56% | 37 |
|
|
2018
Q2 | $17.7M | Sell |
249,257
-3,894
| -2% | -$275K | 0.62% | 30 |
|
|
2018
Q1 | $19.1M | Sell |
253,151
-139
| -0.1% | -$11.1K | 0.64% | 30 |
|
|
2017
Q4 | $18.1M | Buy |
253,290
+116,735
| +85% | +$8.86M | 0.61% | 36 |
|
|
2017
Q3 | $11.1M | Buy |
136,555
+14,884
| +12% | +$1.14M | 0.63% | 31 |
|
|
2017
Q2 | $8.61M | Sell |
121,671
-64,990
| -35% | -$4.32M | 0.52% | 38 |
|
|
2017
Q1 | $12.7M | Buy |
+186,661
| New | +$13.1M | 0.59% | 29 |
|
Other funds holding GILD
Achmea Investment Management's GILD Position: Q4 2025 in Review
Achmea Investment Management sold out of Gilead Sciences (GILD) in Q4 2025, closing a stake of 480,352 shares — an estimated $53.3M sold.
Achmea Investment Management first reported a position in GILD in Q1 2017 and held it in 33 quarters. The position peaked at $53.3M in Q3 2025. 2,216 funds tracked by Wall St. Rank hold GILD as of Q4 2025.
- Achmea Investment Management reported no remaining Gilead Sciences position as of Q4 2025 after selling out during the quarter.
- Achmea Investment Management sold 480,352 Gilead Sciences shares in Q4 2025, an estimated $53.3M.
- Achmea Investment Management first reported a position in Gilead Sciences in Q1 2017 and held it in 33 quarters.
- Achmea Investment Management's Gilead Sciences position peaked at $53.3M in Q3 2025.
- 2,216 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2025.
Based on Achmea Investment Management's 13F filing for Q4 2025, filed 18 Feb 2026.